Trial Profile
A Multi-center, Randomized, Study to Compare the Effectiveness of Sirolimus-eluting Stent (Ultimaster Stent) or Everolimus-eluting Stent (XIience Alpine Stent) for Long Coronary Lesions
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 18 Jun 2020
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Sirolimus (Primary)
- Indications Angina pectoris; Coronary artery disease; Ischaemia; Myocardial infarction
- Focus Therapeutic Use
- Acronyms LONG-DES VII
- 21 Apr 2020 Status changed from recruiting to discontinued.
- 01 Oct 2018 Status changed from not yet recruiting to recruiting.
- 25 Jun 2018 Planned initiation date changed from 30 Apr 2018 to 30 Aug 2018.